US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MasterBrand, Inc.

11.46

-0.0400-0.35%

Volume:1.36M

Turnover:15.54M

Market Cap:1.45B

PE:18.20

High:11.69

Open:11.40

Low:11.32

Close:11.50

52wk High:18.15

52wk Low:9.33

Shares:126.78M

Float Shares:106.28M

Volume Ratio:0.94

T/O Rate:1.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.6298

EPS(LYR):0.9906

ROE:6.19%

ROA:4.73%

PB:1.05

PE(LYR):11.57

Loading ...

Overview Company News Filings

Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million

BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium

Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

We Analyzed 5,000 Calls to Find Out What CEOs Really Think About Tariffs -- WSJ

MasterBrand on Track for Lowest Close Since May 2023 -- Data Talk

MasterBrand Inc - FTC Issues Second Request for MasterBrand-American Woodmark Merger - SEC Filing

THOMSON REUTERS

MasterBrand and American Woodmark Receive FTC Second Request for Merger Review

MasterBrand Inc. reports Q3 2025 net sales of $3.5 billion

MasterBrand Q3 Adj. EPS $0.33 Misses $0.36 Estimate, Sales $698.900M Beat $678.600M Estimate

BRIEF-MasterBrand Q3 Adjusted EPS USD 0.33

MasterBrand Q3 Sales USD 698.9 Million

THOMSON REUTERS

MasterBrand Outlook FY Adjusted EPS USD 1.01-1.13

THOMSON REUTERS

MasterBrand Inc Outlook FY Net Sales Year-Over-Year Approximately Flat

THOMSON REUTERS

MasterBrand-American Woodmark deal receives shareholder approval

Merger Between MasterBrand and American Woodmark Receives Shareholder Approval

THOMSON REUTERS

'I Still Can't Believe It's Around': Cramer Rips Plug Power

Benzinga_recent_news

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

American Woodmark to Merge with MasterBrand in All-Stock Deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MBC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBC\",,,,,undefined,":{"symbol":"MBC","market":"US","secType":"STK","nameCN":"MasterBrand, Inc.","latestPrice":11.46,"timestamp":1766005200000,"preClose":11.5,"halted":0,"volume":1357224,"delay":0,"floatShares":106282458,"shares":126779371,"eps":0.629767,"marketStatus":"Pre-Mkt","change":-0.04,"latestTime":"12-18 08:08:00 EST","open":11.4,"high":11.685,"low":11.315,"amount":15544656.994151998,"amplitude":0.032174,"askPrice":13.56,"askSize":100,"bidPrice":9.61,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.629767,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766068200000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":11.46,"postHourTrading":{"tag":"盘后","latestPrice":11.2301,"preClose":11.46,"latestTime":"19:48 EST","volume":20215,"amount":231623.6675,"timestamp":1766018918248},"volumeRatio":0.9432468969137412,"impliedVol":0.532,"impliedVolPercentile":0.8233},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBC\",,,,,undefined,":{"symbol":"MBC","floatShares":106282458,"roa":"4.73%","roe":"6.19%","lyrEps":0.990558,"volumeRatio":0.9432468969137412,"shares":126779371,"dividePrice":0,"high":11.685,"amplitude":0.032174,"preClose":11.5,"low":11.315,"week52Low":9.33,"pbRate":"1.05","psRate":"0.53","week52High":18.15,"institutionHeld":0,"latestPrice":11.46,"eps":0.629767,"divideRate":0,"volume":1357224,"delay":0,"ttmEps":0.629767,"open":11.4,"prevYearClose":14.61,"prevWeekClose":11.65,"prevMonthClose":11.09,"prevQuarterClose":13.17,"fiveDayClose":11.62,"twentyDayClose":9.44,"sixtyDayClose":13.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBC\",params:#limit:5,,,undefined,":[{"date":"2025-11-04","symbol":"MBC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":null,"defaultRemindTime":1762290000000,"name":null,"time":"Post Market","dateTimestamp":1762232400000,"actualEps":null},{"market":"US","date":"2025-08-06","symbol":"MBC","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.4},{"date":"2025-05-06","symbol":"MBC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1746561600000,"name":null,"time":"Post Market","dateTimestamp":1746504000000,"actualEps":null},{"market":"US","date":"2025-02-18","symbol":"MBC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739854800000,"reportTimeType":"post","actualEps":0.21},{"date":"2024-11-05","symbol":"MBC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":null,"defaultRemindTime":1730840400000,"name":null,"time":"Post Market","dateTimestamp":1730782800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MBC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1683694800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MBC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MBC","date":"2025-12-17","current":18.197206,"percent":0.955645,"low":5.385324,"twenty":8.87038,"median":11.780329,"eighty":14.385264,"high":19.354433,"avg":11.747103,"sd":3.20976,"marketCap":1457962766},"quantilePoints":[{"date":"2022-12-09","current":7.307088,"twenty":7.307088,"median":7.307088,"eighty":7.307088,"marketCap":1280201870},{"date":"2022-12-16","current":6.795592,"twenty":6.211025,"median":6.664065,"eighty":6.795592,"marketCap":1190587739},{"date":"2022-12-23","current":5.538773,"twenty":5.538773,"median":6.189104,"eighty":6.75175,"marketCap":970393017},{"date":"2022-12-30","current":5.516852,"twenty":5.515391,"median":5.633765,"eighty":6.611453,"marketCap":966552411},{"date":"2023-01-06","current":5.516852,"twenty":5.513929,"median":5.626458,"eighty":6.357167,"marketCap":966552411},{"date":"2023-01-13","current":6.057576,"twenty":5.516852,"median":5.637419,"eighty":6.197872,"marketCap":1061287350},{"date":"2023-01-20","current":6.079497,"twenty":5.52562,"median":5.688568,"eighty":6.15403,"marketCap":1065127955},{"date":"2023-01-27","current":6.685986,"twenty":5.538773,"median":5.852978,"eighty":6.48431,"marketCap":1171384711},{"date":"2023-02-03","current":7.131718,"twenty":5.559233,"median":6.013733,"eighty":6.642143,"marketCap":1249477025},{"date":"2023-02-10","current":7.175561,"twenty":5.589923,"median":6.101419,"eighty":6.878893,"marketCap":1257158236},{"date":"2023-02-17","current":7.248632,"twenty":5.604537,"median":6.225639,"eighty":7.084953,"marketCap":1269960255},{"date":"2023-02-24","current":7.065954,"twenty":5.627919,"median":6.47408,"eighty":7.095183,"marketCap":1237955208},{"date":"2023-03-03","current":7.307088,"twenty":5.635226,"median":6.539844,"eighty":7.130257,"marketCap":1280201870},{"date":"2023-03-10","current":7.458136,"twenty":5.642533,"median":6.704254,"eighty":7.1741,"marketCap":1158994286},{"date":"2023-03-17","current":6.68917,"twenty":5.664455,"median":6.75175,"eighty":7.166793,"marketCap":1039497092},{"date":"2023-03-24","current":6.00289,"twenty":5.75214,"median":6.687578,"eighty":7.160852,"marketCap":932849059},{"date":"2023-03-31","current":6.647828,"twenty":5.847132,"median":6.576379,"eighty":7.154721,"marketCap":1033072512},{"date":"2023-04-06","current":6.193064,"twenty":5.852978,"median":6.573412,"eighty":7.131718,"marketCap":962402128},{"date":"2023-04-14","current":6.399775,"twenty":5.940663,"median":6.552494,"eighty":7.124411,"marketCap":994525030},{"date":"2023-04-21","current":6.614754,"twenty":5.969891,"median":6.532537,"eighty":7.11913,"marketCap":1027932848},{"date":"2023-04-28","current":6.474191,"twenty":6.00289,"median":6.494862,"eighty":7.117104,"marketCap":1006089274},{"date":"2023-05-05","current":6.391507,"twenty":6.057576,"median":6.507265,"eighty":7.109797,"marketCap":993240114},{"date":"2023-05-12","current":9.177972,"twenty":6.079497,"median":6.528883,"eighty":7.11913,"marketCap":1317038961},{"date":"2023-05-19","current":9.662843,"twenty":6.101419,"median":6.565144,"eighty":7.160947,"marketCap":1386617915},{"date":"2023-05-26","current":7.646139,"twenty":6.151722,"median":6.574896,"eighty":7.248632,"marketCap":1372481865},{"date":"2023-06-02","current":7.467156,"twenty":6.166605,"median":6.614754,"eighty":7.307088,"marketCap":1340354481},{"date":"2023-06-09","current":7.746369,"twenty":6.176527,"median":6.647828,"eighty":7.383082,"marketCap":1390473201},{"date":"2023-06-16","current":7.989785,"twenty":6.179042,"median":6.672634,"eighty":7.465352,"marketCap":1434166444},{"date":"2023-06-23","current":8.14729,"twenty":6.189104,"median":6.685986,"eighty":7.610342,"marketCap":1462438542},{"date":"2023-06-30","current":8.240361,"twenty":6.192272,"median":6.722521,"eighty":7.665596,"marketCap":1479144782},{"date":"2023-07-07","current":7.853758,"twenty":6.200248,"median":6.773671,"eighty":7.742365,"marketCap":1409749631},{"date":"2023-07-14","current":9.027885,"twenty":6.222716,"median":6.90415,"eighty":7.83944,"marketCap":1620505274},{"date":"2023-07-21","current":8.612645,"twenty":6.244529,"median":6.935825,"eighty":7.892419,"marketCap":1545969742},{"date":"2023-07-28","current":8.777309,"twenty":6.260865,"median":7.000191,"eighty":7.936806,"marketCap":1575526935},{"date":"2023-08-04","current":8.877539,"twenty":6.275748,"median":7.044033,"eighty":8.141562,"marketCap":1593518271},{"date":"2023-08-11","current":10.940689,"twenty":6.279056,"median":7.10249,"eighty":8.234633,"marketCap":1681583951},{"date":"2023-08-18","current":10.400716,"twenty":6.293939,"median":7.118117,"eighty":8.369228,"marketCap":1598590058},{"date":"2023-08-25","current":10.325951,"twenty":6.318744,"median":7.131718,"eighty":8.688534,"marketCap":1587098596},{"date":"2023-09-01","current":10.641627,"twenty":6.343549,"median":7.164601,"eighty":8.745808,"marketCap":1635618102},{"date":"2023-09-08","current":10.226263,"twenty":6.358433,"median":7.175561,"eighty":8.777309,"marketCap":1571776646},{"date":"2023-09-15","current":9.910586,"twenty":6.366701,"median":7.274207,"eighty":8.877539,"marketCap":1523257140},{"date":"2023-09-22","current":10.317643,"twenty":6.383238,"median":7.307088,"eighty":9.063681,"marketCap":1585821767},{"date":"2023-09-29","current":10.001967,"twenty":6.383238,"median":7.372852,"eighty":9.403137,"marketCap":1537302260},{"date":"2023-10-06","current":9.495222,"twenty":6.389853,"median":7.444748,"eighty":9.573221,"marketCap":1459415684},{"date":"2023-10-13","current":9.536759,"twenty":6.398121,"median":7.52963,"eighty":9.585981,"marketCap":1465799829},{"date":"2023-10-20","current":8.764182,"twenty":6.413005,"median":7.628241,"eighty":9.573221,"marketCap":1347054721},{"date":"2023-10-27","current":9.088166,"twenty":6.417636,"median":7.646139,"eighty":9.57156,"marketCap":1396851057},{"date":"2023-11-03","current":9.586602,"twenty":6.426568,"median":7.686154,"eighty":9.57156,"marketCap":1473460804},{"date":"2023-11-10","current":9.265516,"twenty":6.446078,"median":7.753528,"eighty":9.577027,"marketCap":1494527682},{"date":"2023-11-17","current":10.012101,"twenty":6.467577,"median":7.817962,"eighty":9.653619,"marketCap":1614951880},{"date":"2023-11-24","current":10.73511,"twenty":6.474191,"median":7.867392,"eighty":9.68629,"marketCap":1731573209},{"date":"2023-12-01","current":10.546499,"twenty":6.482459,"median":7.889555,"eighty":9.810899,"marketCap":1701150253},{"date":"2023-12-08","current":11.31666,"twenty":6.482459,"median":7.918192,"eighty":9.985352,"marketCap":1825377321},{"date":"2023-12-15","current":12.330445,"twenty":6.495689,"median":7.93967,"eighty":10.012101,"marketCap":1988900706},{"date":"2023-12-22","current":11.678165,"twenty":6.505611,"median":8.061378,"eighty":10.107476,"marketCap":1883687986},{"date":"2023-12-29","current":11.851058,"twenty":6.510572,"median":8.14729,"eighty":10.144696,"marketCap":1911575695},{"date":"2024-01-05","current":11.230214,"twenty":6.515533,"median":8.175927,"eighty":10.184727,"marketCap":1811433467},{"date":"2024-01-12","current":11.607436,"twenty":6.52523,"median":8.240361,"eighty":10.259492,"marketCap":1872279377},{"date":"2024-01-19","current":11.151626,"twenty":6.531076,"median":8.304795,"eighty":10.319305,"marketCap":1798757235},{"date":"2024-01-26","current":11.31666,"twenty":6.538383,"median":8.444401,"eighty":10.420654,"marketCap":1825377321},{"date":"2024-02-02","current":11.222355,"twenty":6.560084,"median":8.66276,"eighty":10.483789,"marketCap":1810165843},{"date":"2024-02-09","current":11.568142,"twenty":6.565144,"median":8.716455,"eighty":10.534634,"marketCap":1865941262},{"date":"2024-02-16","current":12.03181,"twenty":6.571758,"median":8.748672,"eighty":10.634981,"marketCap":1940731027},{"date":"2024-02-23","current":12.086822,"twenty":6.575192,"median":8.764182,"eighty":10.68797,"marketCap":1949604389},{"date":"2024-03-01","current":12.079216,"twenty":6.599404,"median":8.820265,"eighty":10.745413,"marketCap":2198417221},{"date":"2024-03-08","current":12.449059,"twenty":6.624676,"median":8.877539,"eighty":10.984198,"marketCap":2265728667},{"date":"2024-03-15","current":12.456037,"twenty":6.641213,"median":8.894592,"eighty":11.098186,"marketCap":2266998694},{"date":"2024-03-22","current":12.965443,"twenty":6.647828,"median":9.063681,"eighty":11.168915,"marketCap":2359710686},{"date":"2024-03-28","current":13.146876,"twenty":6.65775,"median":9.121395,"eighty":11.22707,"marketCap":2392731395},{"date":"2024-04-05","current":12.853793,"twenty":6.675941,"median":9.17278,"eighty":11.289941,"marketCap":2339390249},{"date":"2024-04-12","current":12.463015,"twenty":6.682936,"median":9.19616,"eighty":11.393677,"marketCap":2268268722},{"date":"2024-04-19","current":11.534918,"twenty":6.68726,"median":9.247452,"eighty":11.486407,"marketCap":2099355093},{"date":"2024-04-26","current":11.695416,"twenty":6.70251,"median":9.353999,"eighty":11.540706,"marketCap":2128565721},{"date":"2024-05-03","current":11.855914,"twenty":6.734213,"median":9.441225,"eighty":11.566018,"marketCap":2157776348},{"date":"2024-05-10","current":11.509468,"twenty":6.769287,"median":9.495222,"eighty":11.602651,"marketCap":2123496931},{"date":"2024-05-17","current":11.289192,"twenty":6.819171,"median":9.536759,"eighty":11.607436,"marketCap":2082855842},{"date":"2024-05-24","current":11.1171,"twenty":6.874383,"median":9.569988,"eighty":11.606342,"marketCap":2051104990},{"date":"2024-05-31","current":11.502585,"twenty":6.907283,"median":9.578295,"eighty":11.603675,"marketCap":2122226897},{"date":"2024-06-07","current":10.903707,"twenty":6.922736,"median":9.639784,"eighty":11.599453,"marketCap":2011733935},{"date":"2024-06-14","current":10.745383,"twenty":6.934986,"median":9.677983,"eighty":11.592793,"marketCap":1982523152},{"date":"2024-06-21","current":10.263527,"twenty":6.937224,"median":9.694597,"eighty":11.568142,"marketCap":1893620768},{"date":"2024-06-28","current":10.105203,"twenty":6.978269,"median":9.810899,"eighty":11.562831,"marketCap":1864409985},{"date":"2024-07-05","current":9.946879,"twenty":6.995807,"median":9.885665,"eighty":11.554505,"marketCap":1835199202},{"date":"2024-07-12","current":10.504455,"twenty":7.011882,"median":9.884926,"eighty":11.546137,"marketCap":1938071960},{"date":"2024-07-19","current":11.426865,"twenty":7.026496,"median":9.939995,"eighty":11.554505,"marketCap":2108256523},{"date":"2024-07-26","current":12.404343,"twenty":7.052801,"median":9.953763,"eighty":11.59908,"marketCap":2288601358},{"date":"2024-08-02","current":11.289192,"twenty":7.064493,"median":9.989505,"eighty":11.607436,"marketCap":2082855842},{"date":"2024-08-09","current":10.785946,"twenty":7.095183,"median":10.012101,"eighty":11.605247,"marketCap":1926369905},{"date":"2024-08-16","current":11.234174,"twenty":7.108336,"median":10.058568,"eighty":11.600602,"marketCap":2006423536},{"date":"2024-08-23","current":11.803354,"twenty":7.115643,"median":10.093347,"eighty":11.600602,"marketCap":2108078940},{"date":"2024-08-30","current":11.412043,"twenty":7.118725,"median":10.108645,"eighty":11.600602,"marketCap":2038190850},{"date":"2024-09-06","current":11.248404,"twenty":7.122299,"median":10.14319,"eighty":11.599204,"marketCap":2008964921},{"date":"2024-09-13","current":11.803354,"twenty":7.128795,"median":10.168112,"eighty":11.599204,"marketCap":2108078940},{"date":"2024-09-20","current":13.425514,"twenty":7.14897,"median":10.226263,"eighty":11.607436,"marketCap":2397796841},{"date":"2024-09-27","current":13.048433,"twenty":7.160757,"median":10.259492,"eighty":11.661524,"marketCap":2330450136},{"date":"2024-10-04","current":12.628663,"twenty":7.165331,"median":10.293039,"eighty":11.678165,"marketCap":2255479276},{"date":"2024-10-11","current":12.650008,"twenty":7.172638,"median":10.317643,"eighty":11.709372,"marketCap":2259291353},{"date":"2024-10-18","current":13.660301,"twenty":7.210635,"median":10.35325,"eighty":11.766917,"marketCap":2439729696},{"date":"2024-10-25","current":12.785188,"twenty":7.242786,"median":10.400716,"eighty":11.781001,"marketCap":2283434512},{"date":"2024-11-01","current":12.543286,"twenty":7.279321,"median":10.425638,"eighty":11.843882,"marketCap":2240230965},{"date":"2024-11-08","current":14.634072,"twenty":7.304165,"median":10.456269,"eighty":11.860259,"marketCap":2165842583},{"date":"2024-11-15","current":14.513839,"twenty":7.307088,"median":10.483789,"eighty":11.892464,"marketCap":2148048102},{"date":"2024-11-22","current":14.762893,"twenty":7.307088,"median":10.500403,"eighty":11.983833,"marketCap":2184908099},{"date":"2024-11-29","current":14.857361,"twenty":7.312934,"median":10.533633,"eighty":12.02865,"marketCap":2198889477},{"date":"2024-12-06","current":14.23902,"twenty":7.362622,"median":10.54422,"eighty":12.066655,"marketCap":2107375002},{"date":"2024-12-13","current":13.938438,"twenty":7.426945,"median":10.621477,"eighty":12.094077,"marketCap":2062888798},{"date":"2024-12-20","current":12.418349,"twenty":7.44207,"median":10.641627,"eighty":12.234192,"marketCap":1837915713},{"date":"2024-12-27","current":12.401173,"twenty":7.45994,"median":10.689938,"eighty":12.246671,"marketCap":1835373644},{"date":"2025-01-03","current":12.650227,"twenty":7.467156,"median":10.729905,"eighty":12.351364,"marketCap":1872233641},{"date":"2025-01-10","current":12.967986,"twenty":7.517135,"median":10.736804,"eighty":12.387651,"marketCap":1919261913},{"date":"2025-01-17","current":14.659836,"twenty":7.577017,"median":10.745383,"eighty":12.418349,"marketCap":2169655686},{"date":"2025-01-24","current":14.926066,"twenty":7.601751,"median":10.766545,"eighty":12.43462,"marketCap":2209057752},{"date":"2025-01-31","current":14.874537,"twenty":7.63182,"median":10.841731,"eighty":12.463819,"marketCap":2201431546},{"date":"2025-02-07","current":14.324901,"twenty":7.646139,"median":10.876568,"eighty":12.535311,"marketCap":2120085345},{"date":"2025-02-14","current":14.496662,"twenty":7.65473,"median":10.893382,"eighty":12.550401,"marketCap":2145506033},{"date":"2025-02-21","current":14.498659,"twenty":7.670736,"median":10.930907,"eighty":12.577182,"marketCap":1825381114},{"date":"2025-02-28","current":14.184352,"twenty":7.706236,"median":10.986311,"eighty":12.613961,"marketCap":1785809915},{"date":"2025-03-07","current":13.971435,"twenty":7.740363,"median":11.041728,"eighty":12.651384,"marketCap":1759003619},{"date":"2025-03-14","current":13.576017,"twenty":7.752096,"median":11.049461,"eighty":12.760285,"marketCap":1709220498},{"date":"2025-03-21","current":13.535461,"twenty":7.766415,"median":11.05732,"eighty":12.818141,"marketCap":1704114537},{"date":"2025-03-28","current":13.281988,"twenty":7.792188,"median":11.082682,"eighty":12.845494,"marketCap":1672202279},{"date":"2025-04-04","current":12.683792,"twenty":7.83228,"median":11.098994,"eighty":12.859587,"marketCap":1596889352},{"date":"2025-04-11","current":12.399902,"twenty":7.859212,"median":11.1171,"eighty":12.851377,"marketCap":1561147624},{"date":"2025-04-17","current":11.791566,"twenty":7.867529,"median":11.135908,"eighty":12.846624,"marketCap":1484558207},{"date":"2025-04-25","current":12.004484,"twenty":7.869509,"median":11.155556,"eighty":12.840683,"marketCap":1511364503},{"date":"2025-05-02","current":12.663514,"twenty":7.880964,"median":11.177256,"eighty":12.834108,"marketCap":1594336372},{"date":"2025-05-09","current":12.299895,"twenty":7.906738,"median":11.187273,"eighty":12.840683,"marketCap":1250899322},{"date":"2025-05-16","current":13.919942,"twenty":7.918192,"median":11.203509,"eighty":12.86345,"marketCap":1415658098},{"date":"2025-05-23","current":12.39959,"twenty":7.921056,"median":11.224797,"eighty":12.872472,"marketCap":1261038324},{"date":"2025-05-30","current":12.798371,"twenty":7.932511,"median":11.230214,"eighty":12.86345,"marketCap":1301594330},{"date":"2025-06-06","current":12.873142,"twenty":7.93967,"median":11.241006,"eighty":12.86345,"marketCap":1309198581},{"date":"2025-06-13","current":13.109918,"twenty":7.953989,"median":11.25772,"eighty":12.934597,"marketCap":1333278710},{"date":"2025-06-20","current":12.436976,"twenty":7.982626,"median":11.273305,"eighty":12.905372,"marketCap":1264840449},{"date":"2025-06-27","current":13.521161,"twenty":8.104334,"median":11.28462,"eighty":12.961389,"marketCap":1375102092},{"date":"2025-07-03","current":14.455804,"twenty":8.141562,"median":11.289192,"eighty":12.988433,"marketCap":1470155232},{"date":"2025-07-11","current":15.029051,"twenty":8.160177,"median":11.307062,"eighty":13.040508,"marketCap":1528454491},{"date":"2025-07-18","current":14.243951,"twenty":8.177359,"median":11.31666,"eighty":13.073463,"marketCap":1448609853},{"date":"2025-07-25","current":14.505651,"twenty":8.20886,"median":11.340896,"eighty":13.152458,"marketCap":1475224732},{"date":"2025-08-01","current":13.745475,"twenty":8.234633,"median":11.412043,"eighty":13.180599,"marketCap":1397914845},{"date":"2025-08-08","current":16.203164,"twenty":8.279021,"median":11.438562,"eighty":13.222341,"marketCap":1518236469},{"date":"2025-08-15","current":17.190502,"twenty":8.304795,"median":11.465977,"eighty":13.349109,"marketCap":1610750044},{"date":"2025-08-22","current":16.595394,"twenty":8.304795,"median":11.501306,"eighty":13.406819,"marketCap":1554988437},{"date":"2025-08-29","current":17.312229,"twenty":8.369228,"median":11.51313,"eighty":13.526881,"marketCap":1622155827},{"date":"2025-09-05","current":17.663883,"twenty":8.437958,"median":11.530119,"eighty":13.558712,"marketCap":1655105867},{"date":"2025-09-12","current":18.245466,"twenty":8.531029,"median":11.539741,"eighty":13.595933,"marketCap":1709600164},{"date":"2025-09-19","current":18.164315,"twenty":8.632691,"median":11.548232,"eighty":13.632794,"marketCap":1701996309},{"date":"2025-09-26","current":17.433955,"twenty":8.679942,"median":11.557627,"eighty":13.689573,"marketCap":1633561610},{"date":"2025-10-03","current":18.110214,"twenty":8.705716,"median":11.598956,"eighty":13.73447,"marketCap":1696927072},{"date":"2025-10-10","current":17.799135,"twenty":8.714307,"median":11.606068,"eighty":13.822739,"marketCap":1667778959},{"date":"2025-10-17","current":17.44748,"twenty":8.732921,"median":11.607436,"eighty":13.909353,"marketCap":1634828919},{"date":"2025-10-24","current":17.569207,"twenty":8.744376,"median":11.639591,"eighty":13.948744,"marketCap":1646234702},{"date":"2025-10-31","current":17.122876,"twenty":8.751536,"median":11.662447,"eighty":13.987657,"marketCap":1604413497},{"date":"2025-11-07","current":16.955016,"twenty":8.759171,"median":11.676323,"eighty":14.044367,"marketCap":1402179843},{"date":"2025-11-14","current":15.713284,"twenty":8.769433,"median":11.68156,"eighty":14.098176,"marketCap":1299488552},{"date":"2025-11-21","current":14.670841,"twenty":8.788764,"median":11.712861,"eighty":14.186236,"marketCap":1213278580},{"date":"2025-11-28","current":17.077656,"twenty":8.811673,"median":11.739814,"eighty":14.242965,"marketCap":1412322192},{"date":"2025-12-05","current":17.200297,"twenty":8.836015,"median":11.764164,"eighty":14.276808,"marketCap":1422464542},{"date":"2025-12-12","current":18.273399,"twenty":8.848902,"median":11.779742,"eighty":14.345512,"marketCap":1511210102},{"date":"2025-12-17","current":17.629538,"twenty":8.87038,"median":11.780329,"eighty":14.385264,"marketCap":1457962766}],"updateTime":1766063280671},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592903304","title":"Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2592903304","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592903304?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:02","pubTimestamp":1766059320,"startTime":"0","endTime":"0","summary":"Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations Financing C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/18/3207578/0/en/Athira-Pharma-Announces-Exclusive-License-to-Lasofoxifene-Phase-3-Development-Program-for-Metastatic-Breast-Cancer-Candidate-and-a-Financing-for-up-to-236-Million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBC","NEA","BK4086","BK4007","ATHA"],"gpt_icon":0},{"id":"2590346407","title":"BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2590346407","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590346407?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:30","pubTimestamp":1765283400,"startTime":"0","endTime":"0","summary":"Over 230 patients screened and over 160 patients enrolled in BriaCell’s pivotal Phase 3 study in metastatic breast cancer (MBC)Enrollment exceeding expectations with strong clinical site and patient i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/09/3202256/0/en/BriaCell-s-Phase-3-Patient-Enrollment-on-Track-for-1H2026-Topline-Data-Readout.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","BCTX","BK4139","MBC","BK4097","BK4086","CPI"],"gpt_icon":0},{"id":"2588405322","title":"Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2588405322","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588405322?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:00","pubTimestamp":1764680400,"startTime":"0","endTime":"0","summary":"Immunotherapy-chemotherapy combination of eftilagimod alfa (efti) and paclitaxel led to strong objective response rates and immune activation in heavily pretreated metastatic breast cancer patientsAIP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197884/0/en/Immutep-to-Present-New-Data-from-AIPAC-003-Phase-II-at-the-2025-San-Antonio-Breast-Cancer-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU2265009873.SGD","BK4144","BK4139","BK4590","BK4585","ALC","BK4198","IMMP","BK4086","BK4581","LU0053666078.USD","LU2487616109.SGD","BK4107","BK4561","LU1169589451.USD","LU1804176565.USD","ET","LU1169590202.USD","BK4588","BK4534","ORR","LU0210528500.USD","MBC","L","PD"],"gpt_icon":0},{"id":"2586628532","title":"Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America","url":"https://stock-news.laohu8.com/highlight/detail?id=2586628532","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586628532?lang=en_us&edition=fundamental","pubTime":"2025-11-26 09:06","pubTimestamp":1764119160,"startTime":"0","endTime":"0","summary":"SINGAPORE, Nov. 26, 2025 /PRNewswire/ --Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar development and commercialization, for the commercialization of Tuznue  across Latin American markets, including Argentina, Mexico, Bolivia, and Paraguay.Tuznue is a biosimilar to Herceptin , approved for the treatment of breast cancer and metastatic gastric cancer. Prestige Biopharma received European Commission  marketing authorization for Tuznue in September 2024. This approval marks a major milestone for the company's biosimilar portfolio, signaling progress in expanding access to cost-effective treatments across key global markets.Under the agreement, Biosidus secures exclusive rights to market and distribute Tuznue in Argentina, Mexico, Bolivia, and Paraguay, leveraging its exte","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/prestige-biopharma-and-biosidus-enter-exclusive-license-agreement-for-tuznue-commercialization-in-latin-america-302626222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","BK4007","PBH","BK4086","BK4211","MGC","MGC.AU","BK4201","EBC","MBC"],"gpt_icon":1},{"id":"2585461952","title":"Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585461952","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585461952?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:00","pubTimestamp":1763985600,"startTime":"0","endTime":"0","summary":"NEW HAVEN, Conn., Nov.  24, 2025  (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193339/0/en/Arvinas-Announces-Data-Presentations-from-the-Vepdegestrant-ARV-471-Clinical-Development-Program-at-the-2025-San-Antonio-Breast-Cancer-Symposium-SABCS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0289739699.SGD","BK4086","BK4585","LU0122379950.USD","LU0225771236.USD","LU0321505439.SGD","BK4190","IE0002270589.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU1894683348.USD","SG9999001176.SGD","SG9999011175.SGD","LU0170899867.USD","BK4588","IE00BLSP4239.USD","SG9999002224.SGD","BC","IE00BBT3K403.USD","BK4561","LU1066051498.USD","IE000M9KFDE8.USD","LU1057294990.SGD","SG9999013999.USD","LU0058720904.USD","BK4581","BK4568","BK4550","MBC","LU1023059063.AUD","SG9999001176.USD","BK4007","LU0306806265.USD","BK4533","LU1883839398.USD","BK4144","LU0456855351.SGD","BK4590","LU1066053197.SGD","SG9999002232.USD","LU0225284248.USD","ET","BK4592","LU0306807586.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU0868494617.USD"],"gpt_icon":1},{"id":"2585102800","title":"We Analyzed 5,000 Calls to Find Out What CEOs Really Think About Tariffs -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2585102800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585102800?lang=en_us&edition=fundamental","pubTime":"2025-11-23 10:00","pubTimestamp":1763863200,"startTime":"0","endTime":"0","summary":"Executives are starting to chill out about tariffs after a year of anxiety.Months into President Trump's roller coaster of a global trade war, something has shifted. Business leaders sound less gloomy about tariffs than they have for much of the year. They are talking less about risk when they discuss them with investors. And the subject is no longer dominating earnings calls like before.\"We believe that the worst of the tariff and economic disruptions to our businesses are now behind us,\" said David Maura, chief executive of Spectrum Brands, which sells everything from pet food to insect repellent, on a call with investors this month.And for good reason. The real tariffs companies pay have turned out to be lower than the headline figures. Companies paid about 12% of the value of their imports as tariffs in October, consulting firm Oxford Economics estimates. That is about 10 percentage points higher than in January, but well below the most dramatic rates announced by the administratio","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4018","BK4086","BK4099","BK4588","SPB","BK4574","BK4504","BK4585","BK4533","HSY","F","BK4532","LU2065732104.USD","MBC","BK4212","LU0170899867.USD","BK4516","BK4555"],"gpt_icon":0},{"id":"2584895243","title":"MasterBrand on Track for Lowest Close Since May 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2584895243","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584895243?lang=en_us&edition=fundamental","pubTime":"2025-11-19 01:37","pubTimestamp":1763487420,"startTime":"0","endTime":"0","summary":"MasterBrand Inc  is currently at $9.65, down $0.17 or 1.68%. --Would be lowest close since May 9, 2023, when it closed at $8.64. --On pace for largest percent decrease since Nov. 17, 2025, when it fell 3.25%. --Currently down eight consecutive days; down 12.7% over this period. --Longest losing streak since March 15, 2023, when it fell for eight straight trading days. --Down 33.92% year-to-date; on pace for worst year on record . --Down 49.71% from its all-time closing high of $19.20 on Oct. 18, 2024. --Down 41.84% from 52 weeks ago , when it closed at $16.60. --Down 46.15% from its 52-week closing high of $17.93 on Jan. 27, 2025. --Traded as low as $9.61; lowest intraday level since May 9, 2023, when it hit $8.30","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","MBC"],"gpt_icon":0},{"id":"2581834198","title":"MasterBrand Inc - FTC Issues Second Request for MasterBrand-American Woodmark Merger - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834198","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581834198?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:57","pubTimestamp":1762552670,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ12K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBC","BK4086"],"gpt_icon":0},{"id":"2581834942","title":"MasterBrand and American Woodmark Receive FTC Second Request for Merger Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834942","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581834942?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:54","pubTimestamp":1762552446,"startTime":"0","endTime":"0","summary":"MasterBrand, Inc. and American Woodmark Corporation have each received a request for additional information from the U.S. Federal Trade Commission regarding their planned merger. This request is expected to extend the timeline for the completion of the transaction. Both companies stated they are working cooperatively with the FTC to secure regulatory clearance and now anticipate closing the deal in early 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MasterBrand Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 07, 2025, and is solely responsible for the information cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL1Kt34X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","AMWD","MBC"],"gpt_icon":0},{"id":"2581761484","title":"MasterBrand Inc. reports Q3 2025 net sales of $3.5 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2581761484","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581761484?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:08","pubTimestamp":1762290485,"startTime":"0","endTime":"0","summary":"MasterBrand Inc. reported 2024 net sales of $2.7 billion and adjusted EBITDA of $364 million. The company's adjusted EBITDA margin was 13%. The period marks the first with the Supreme acquisition fully annualized in year-over-year comparisons, following its close on July 10, 2024. MasterBrand expects to realize annual run-rate cost synergies of $90 million by the end of year three post-acquisition and anticipates accretion to adjusted diluted EPS in year two. Approximately 60% of net sales were attributed to the repair and remodel segment. The company's distribution network includes more than 13,000 employees, over 20 manufacturing facilities, and a dealer network of over 7,700.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MasterBran","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL3vMdMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","MBC"],"gpt_icon":0},{"id":"2581240769","title":"MasterBrand Q3 Adj. EPS $0.33 Misses $0.36 Estimate, Sales $698.900M Beat $678.600M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581240769","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581240769?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:07","pubTimestamp":1762290424,"startTime":"0","endTime":"0","summary":"MasterBrand (NYSE:MBC) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.36 by 8.33 percent. This is a 17.5 percent decrease over earnings of $0.40 per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48637126/masterbrand-q3-adj-eps-0-33-misses-0-36-estimate-sales-698-900m-beat-678-600m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MasterBrand Q3 Adj. EPS $0.33 Misses $0.36 Estimate, Sales $698.900M Beat $678.600M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","MBC"],"gpt_icon":0},{"id":"2581769088","title":"BRIEF-MasterBrand Q3 Adjusted EPS USD 0.33","url":"https://stock-news.laohu8.com/highlight/detail?id=2581769088","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581769088?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:05","pubTimestamp":1762290349,"startTime":"0","endTime":"0","summary":"BRIEF-MasterBrand Q3 Adjusted EPS USD 0.33\n\n\nNov 04 (Reuters) - MasterBrand Q3 sales USD 698.9 million.\n\nQ3 net income USD 18.1 million\nQ3 gross margin 31.2%\nQ3 operating income USD 41.7 million\nQ3 pretax profit USD 23.4 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX42B89E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","MBC"],"gpt_icon":0},{"id":"2581769178","title":"MasterBrand Q3 Sales USD 698.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581769178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581769178?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:05","pubTimestamp":1762290307,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX42B89E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4086","MBC"],"gpt_icon":0},{"id":"2581623637","title":"MasterBrand Outlook FY Adjusted EPS USD 1.01-1.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2581623637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581623637?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:05","pubTimestamp":1762290307,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX42B89E:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4086","MBC"],"gpt_icon":0},{"id":"2581359762","title":"MasterBrand Inc Outlook FY Net Sales Year-Over-Year Approximately Flat","url":"https://stock-news.laohu8.com/highlight/detail?id=2581359762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581359762?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:05","pubTimestamp":1762290307,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX42B89E:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBC","BK4086"],"gpt_icon":0},{"id":"2579086841","title":"MasterBrand-American Woodmark deal receives shareholder approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2579086841","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579086841?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:50","pubTimestamp":1761857443,"startTime":"0","endTime":"0","summary":"MasterBrand (MBC) and American Woodmark (AMWD) jointly announced that, at their respective special meetings of shareholders held earlier today, the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/masterbrand-american-woodmark-deal-receives-shareholder-approval-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/masterbrand-american-woodmark-deal-receives-shareholder-approval-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMWD","BK4086","MBC"],"gpt_icon":0},{"id":"2579171745","title":"Merger Between MasterBrand and American Woodmark Receives Shareholder Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2579171745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579171745?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:05","pubTimestamp":1761854701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA9JNGXK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4086","MBC"],"gpt_icon":0},{"id":"2579085879","title":"'I Still Can't Believe It's Around': Cramer Rips Plug Power","url":"https://stock-news.laohu8.com/highlight/detail?id=2579085879","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579085879?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:54","pubTimestamp":1761738840,"startTime":"0","endTime":"0","summary":"Mad Money Lightning Round: Jim Cramer says Sempra (SRE) is a buy, supported by Wells Fargo's Overweight rating. Pfizer (PFE) and Dow (DOW) discussed. Plug Power (PLUG) faces concerns over shareholder dilution.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/29/Jim-Cramer--AI-Is-Bigger-Than-Rate-Cuts.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/29/Jim-Cramer--AI-Is-Bigger-Than-Rate-Cuts.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/long-ideas/25/10/48489555/i-still-cant-believe-its-around-cramer-rips-plug-power","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/25/10/48489555/i-still-cant-believe-its-around-cramer-rips-plug-power","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","BK4541","LU0048573561.USD","LU1894683264.USD","LU1621768206.USD","LU0868494617.USD","BK4096","SG9999002224.SGD","LU0823414478.USD","LU0238689110.USD","BK4588","IE0002270589.USD","DOW","IE00B29SXL02.USD","LU2357305700.SGD","LU1023059063.AUD","IE00B19Z3581.USD","LU0234572021.USD","LU0985481810.HKD","LU0306807586.USD","IE00B19Z3B42.SGD","BK4568","SRE","BK4599","PLUG","LU0170899867.USD","BK4550","LU0306806265.USD","LU0321505868.SGD","BK4208","SG9999011175.SGD","SG9999001176.SGD","LU0225771236.USD","SG9999003800.SGD","IE00B29SXK94.USD","BK4090","IE00BBT3K403.USD","BK4581","LU2384288077.EUR","LU0742534661.SGD","LU2449327464.USD","LU0321505439.SGD","LU0456855351.SGD","SG9999013999.USD","LU0122379950.USD","IE000M9KFDE8.USD","LU0058720904.USD","MBC","LU0225284248.USD"],"gpt_icon":1},{"id":"2577827079","title":"BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2577827079","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577827079?lang=en_us&edition=fundamental","pubTime":"2025-10-21 19:50","pubTimestamp":1761047400,"startTime":"0","endTime":"0","summary":"79 clinical sites across 23 US states are currently enrolling patients in BriaCell’s pivotal Phase 3 study in metastatic breast cancer (MBC)Dartmouth Cancer Center, Cedars-Sinai Medical Center, and Wi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/21/3170091/0/en/BriaCell-Adds-Key-Clinical-Sites-in-Phase-3-Metastatic-Breast-Cancer-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4086","CPI","OS","BK4139","MBC","BCTX"],"gpt_icon":0},{"id":"2577948098","title":"American Woodmark to Merge with MasterBrand in All-Stock Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2577948098","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577948098?lang=en_us&edition=fundamental","pubTime":"2025-10-21 06:45","pubTimestamp":1761000338,"startTime":"0","endTime":"0","summary":"American Woodmark Corporation has entered into an agreement with MasterBrand, Inc. under which American Woodmark will merge with a wholly owned subsidiary of MasterBrand. Following the completion of the transaction, American Woodmark will become a wholly owned subsidiary of MasterBrand. As part of the ongoing process, MasterBrand has filed a registration statement with the SEC relating to the merger. Recent updates include additional information about executive retention awards at American Woodmark and further details on the evaluation process and potential value creation from the business combination.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AWC - American Woodmark Corporation published the original content used to generate this","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDL9Mb9cc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMWD","MBC","BK4086"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}